Thyroidectomy evaluation, used as the First-Line Treatment for Thyroid Cancer: A Retrospective Study

Abstract

Aim: To evaluate the outcome of Thyroidectomy, used as the First-Line Treatment for Thyroid Cancer

Study design: A retrospective study

Place and Duration: This study was conducted at Liaquat University of Medical Health Sciences Jamshoro, Pakistan from June 2017 to June 2021.

Methodology: A total of 120 participants with differentiated thyroid carcinoma who had their thyroid removed completely were included in this study. The link between individual (gender and age) and tumor (size and histotype) attributes and clinical and pathological aspects (extra thyroid tumor development, bilaterality, nodal and distant metastases) was assessed. Furthermore, we documented postoperative problems such as hypoparathyroidism and injury to the laryngeal nerve.

Results: We observed a high prevalence of pathological characteristics that indicate cancer severity. In 54 (41 percent) of participants with pre - operatively confirmed lymph node metastases, unilateral or bilateral lymph node excision was done. On the premise of a fine-needle aspiration cytology (FNAC) detection of cancer, complete thyroidectomy was performed in 95 participants as a primary therapy.

Conclusion: Our findings back up the idea that complete thyroidectomy is still the best therapeutic option for differentiated thyroid carcinoma. Total thyroidectomy, on the contrary, was linked to a reduced prevalence of postoperative complications.